Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study
NCT03387722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 253
Last updated 2020-09-10
Summary
SevEos is a cross-sectional, multi-center, non-interventional study aimed to describe the treatment patterns in 250 severe asthma patients across the Gulf region. In addition, the study will determine the current level of asthma control and quality of life in these patients; describe the exacerbation patterns; and determine the current levels of blood eosinophils for the enrolled patients.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-31
- Primary Completion
- 2019-01-03
- Completion
- 2019-01-03
Countries
- Oman
- United Arab Emirates
Study Locations
More Related Trials
-
Repeat Dose Safety Study for Compound to Treat Asthma
NCT01202214 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects
NCT03622112 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
NCT01147744 ·Status: COMPLETED ·Phase: PHASE2
-
This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
NCT06862206 ·Status: RECRUITING
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma
NCT03207243 ·Status: COMPLETED ·Phase: PHASE2
-
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04719832 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients
NCT03931954 ·Status: COMPLETED
-
Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients
NCT01907763 ·Status: TERMINATED ·Phase: PHASE3
-
A Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic Asthma
NCT03739320 ·Status: UNKNOWN
-
A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)
NCT01245426 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
NCT01000506 ·Status: COMPLETED ·Phase: PHASE2
-
Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma
NCT00830505 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04718103 ·Status: COMPLETED ·Phase: PHASE3
-
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
NCT04991805 ·Status: COMPLETED
-
Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
NCT03393806 ·Status: TERMINATED ·Phase: PHASE2
-
Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population
NCT02153411 ·Status: COMPLETED
-
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT05593250 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)
NCT04609904 ·Status: COMPLETED ·Phase: PHASE3
-
A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma
NCT01202097 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04718389 ·Status: COMPLETED ·Phase: PHASE3